• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Oncolytic Virus Market Research Report 2020

report cover
  • 22 June 2020
  • Healthcare
  • 122 Pages
  • Report Code: 24LS-8449
  • Formate :   
Download FREE Report Sample Download PDF File

Oncolytic Virus -MARKET ADVISORY SERVICES

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Oncolytic Virus market is segmented into
Imlygic
Oncorine
Others
Imlygic is the most widely used type which takes up about 85% of the total market share in 2019.

Segment by Application
Melanoma
Other Cancers
The application of oncolytic virus therapy includes melanoma and other cancer, and the proportion of sales for melanoma in 2018 is about 85.52%.

Global Oncolytic Virus Market: Regional Analysis
The Oncolytic Virus market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Oncolytic Virus market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Global Oncolytic Virus Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Oncolytic Virus market include:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
1 Oncolytic Virus Market Overview
1.1 Product Overview and Scope of Oncolytic Virus
1.2 Oncolytic Virus Segment by Type
1.2.1 Global Oncolytic Virus Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Oncolytic Virus Segment by Application
1.3.1 Oncolytic Virus Sales Comparison by Application: 2020 VS 2026
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Global Oncolytic Virus Market Size Estimates and Forecasts
1.4.1 Global Oncolytic Virus Revenue 2015-2026
1.4.2 Global Oncolytic Virus Sales 2015-2026
1.4.3 Oncolytic Virus Market Size by Region: 2020 Versus 2026
1.5 Oncolytic Virus Industry
1.6 Oncolytic Virus Market Trends

2 Global Oncolytic Virus Market Competition by Manufacturers
2.1 Global Oncolytic Virus Sales Market Share by Manufacturers (2015-2020)
2.2 Global Oncolytic Virus Revenue Share by Manufacturers (2015-2020)
2.3 Global Oncolytic Virus Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oncolytic Virus Manufacturing Sites, Area Served, Product Type
2.5 Oncolytic Virus Market Competitive Situation and Trends
2.5.1 Oncolytic Virus Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Oncolytic Virus Players (Opinion Leaders)

3 Oncolytic Virus Retrospective Market Scenario by Region
3.1 Global Oncolytic Virus Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Oncolytic Virus Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Oncolytic Virus Market Facts & Figures by Country
3.3.1 North America Oncolytic Virus Sales by Country
3.3.2 North America Oncolytic Virus Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oncolytic Virus Market Facts & Figures by Country
3.4.1 Europe Oncolytic Virus Sales by Country
3.4.2 Europe Oncolytic Virus Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncolytic Virus Market Facts & Figures by Region
3.5.1 Asia Pacific Oncolytic Virus Sales by Region
3.5.2 Asia Pacific Oncolytic Virus Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oncolytic Virus Market Facts & Figures by Country
3.6.1 Latin America Oncolytic Virus Sales by Country
3.6.2 Latin America Oncolytic Virus Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncolytic Virus Sales by Country
3.7.2 Middle East and Africa Oncolytic Virus Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oncolytic Virus Historic Market Analysis by Type
4.1 Global Oncolytic Virus Sales Market Share by Type (2015-2020)
4.2 Global Oncolytic Virus Revenue Market Share by Type (2015-2020)
4.3 Global Oncolytic Virus Price Market Share by Type (2015-2020)
4.4 Global Oncolytic Virus Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Oncolytic Virus Historic Market Analysis by Application
5.1 Global Oncolytic Virus Sales Market Share by Application (2015-2020)
5.2 Global Oncolytic Virus Revenue Market Share by Application (2015-2020)
5.3 Global Oncolytic Virus Price by Application (2015-2020)

6 Company Profiles and Key Figures in Oncolytic Virus Business
6.1 Amgen
6.1.1 Corporation Information
6.1.2 Amgen Description, Business Overview and Total Revenue
6.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Amgen Products Offered
6.1.5 Amgen Recent Development
6.2 Oncolytics Biotech
6.2.1 Oncolytics Biotech Corporation Information
6.2.2 Oncolytics Biotech Description, Business Overview and Total Revenue
6.2.3 Oncolytics Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Oncolytics Biotech Products Offered
6.2.5 Oncolytics Biotech Recent Development
6.3 Viralytics
6.3.1 Viralytics Corporation Information
6.3.2 Viralytics Description, Business Overview and Total Revenue
6.3.3 Viralytics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Viralytics Products Offered
6.3.5 Viralytics Recent Development
6.4 Transgene SA
6.4.1 Transgene SA Corporation Information
6.4.2 Transgene SA Description, Business Overview and Total Revenue
6.4.3 Transgene SA Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Transgene SA Products Offered
6.4.5 Transgene SA Recent Development
6.5 Oncolys BioPharma
6.5.1 Oncolys BioPharma Corporation Information
6.5.2 Oncolys BioPharma Description, Business Overview and Total Revenue
6.5.3 Oncolys BioPharma Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Oncolys BioPharma Products Offered
6.5.5 Oncolys BioPharma Recent Development
6.6 Targovax
6.6.1 Targovax Corporation Information
6.6.2 Targovax Description, Business Overview and Total Revenue
6.6.3 Targovax Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Targovax Products Offered
6.6.5 Targovax Recent Development
6.7 PsiOxus Therapeutics
6.6.1 PsiOxus Therapeutics Corporation Information
6.6.2 PsiOxus Therapeutics Description, Business Overview and Total Revenue
6.6.3 PsiOxus Therapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.4.4 PsiOxus Therapeutics Products Offered
6.7.5 PsiOxus Therapeutics Recent Development
6.8 SillaJen Biotherapeutics
6.8.1 SillaJen Biotherapeutics Corporation Information
6.8.2 SillaJen Biotherapeutics Description, Business Overview and Total Revenue
6.8.3 SillaJen Biotherapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.8.4 SillaJen Biotherapeutics Products Offered
6.8.5 SillaJen Biotherapeutics Recent Development
6.9 Sorrento Therapeutics
6.9.1 Sorrento Therapeutics Corporation Information
6.9.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
6.9.3 Sorrento Therapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Sorrento Therapeutics Products Offered
6.9.5 Sorrento Therapeutics Recent Development
6.10 Lokon Pharma
6.10.1 Lokon Pharma Corporation Information
6.10.2 Lokon Pharma Description, Business Overview and Total Revenue
6.10.3 Lokon Pharma Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lokon Pharma Products Offered
6.10.5 Lokon Pharma Recent Development
6.11 Genelux Corporation
6.11.1 Genelux Corporation Corporation Information
6.11.2 Genelux Corporation Oncolytic Virus Description, Business Overview and Total Revenue
6.11.3 Genelux Corporation Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Genelux Corporation Products Offered
6.11.5 Genelux Corporation Recent Development
6.12 Vyriad
6.12.1 Vyriad Corporation Information
6.12.2 Vyriad Oncolytic Virus Description, Business Overview and Total Revenue
6.12.3 Vyriad Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Vyriad Products Offered
6.12.5 Vyriad Recent Development
6.13 TILT Biotherapeutics
6.13.1 TILT Biotherapeutics Corporation Information
6.13.2 TILT Biotherapeutics Oncolytic Virus Description, Business Overview and Total Revenue
6.13.3 TILT Biotherapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.13.4 TILT Biotherapeutics Products Offered
6.13.5 TILT Biotherapeutics Recent Development
6.14 Cold Genesys
6.14.1 Cold Genesys Corporation Information
6.14.2 Cold Genesys Oncolytic Virus Description, Business Overview and Total Revenue
6.14.3 Cold Genesys Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Cold Genesys Products Offered
6.14.5 Cold Genesys Recent Development

7 Oncolytic Virus Manufacturing Cost Analysis
7.1 Oncolytic Virus Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncolytic Virus
7.4 Oncolytic Virus Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncolytic Virus Distributors List
8.3 Oncolytic Virus Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Oncolytic Virus Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Oncolytic Virus by Type (2021-2026)
10.2 Oncolytic Virus Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncolytic Virus by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Oncolytic Virus by Application (2021-2026)
10.3 Oncolytic Virus Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncolytic Virus by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Oncolytic Virus by Region (2021-2026)
10.4 North America Oncolytic Virus Estimates and Projections (2021-2026)
10.5 Europe Oncolytic Virus Estimates and Projections (2021-2026)
10.6 Asia Pacific Oncolytic Virus Estimates and Projections (2021-2026)
10.7 Latin America Oncolytic Virus Estimates and Projections (2021-2026)
10.8 Middle East and Africa Oncolytic Virus Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables

Table 1. Global Oncolytic Virus Sales (K Units) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Oncolytic Virus Sales (K Units) Comparison by Application: 2020 VS 2026

Table 3. Global Oncolytic Virus Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

Table 4. Global Key Oncolytic Virus Manufacturers Covered in This Study

Table 5. Global Oncolytic Virus Sales (K Units) by Manufacturers (2015-2020)

Table 6. Global Oncolytic Virus Sales Share by Manufacturers (2015-2020)

Table 7. Global Oncolytic Virus Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Oncolytic Virus Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Oncolytic Virus Average Price (US$/Unit) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Oncolytic Virus Sales Sites and Area Served

Table 11. Manufacturers Oncolytic Virus Product Types

Table 12. Global Oncolytic Virus Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus as of 2019)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Oncolytic Virus Players

Table 16. Global Oncolytic Virus Sales (K Units) by Region (2015-2020)

Table 17. Global Oncolytic Virus Sales Market Share by Region (2015-2020)

Table 18. Global Oncolytic Virus Revenue (Million US$) by Region (2015-2020)

Table 19. Global Oncolytic Virus Revenue Market Share by Region (2015-2020)

Table 20. North America Oncolytic Virus Sales by Country (2015-2020) (K Units)

Table 21. North America Oncolytic Virus Sales Market Share by Country (2015-2020)

Table 22. North America Oncolytic Virus Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Oncolytic Virus Revenue Market Share by Country (2015-2020)

Table 24. Europe Oncolytic Virus Sales by Country (2015-2020) (K Units)

Table 25. Europe Oncolytic Virus Sales Market Share by Country (2015-2020)

Table 26. Europe Oncolytic Virus Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Oncolytic Virus Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Oncolytic Virus Sales by Region (2015-2020) (K Units)

Table 29. Asia Pacific Oncolytic Virus Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Oncolytic Virus Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Oncolytic Virus Revenue Market Share by Region (2015-2020)

Table 32. Latin America Oncolytic Virus Sales by Country (2015-2020) (K Units)

Table 33. Latin America Oncolytic Virus Sales Market Share by Country (2015-2020)

Table 34. Latin America Oncolytic Virus Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Oncolytic Virus Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Oncolytic Virus Sales by Country (2015-2020) (K Units)

Table 37. Middle East and Africa Oncolytic Virus Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Oncolytic Virus Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2015-2020)

Table 40. Global Oncolytic Virus Sales (K Units) by Type (2015-2020)

Table 41. Global Oncolytic Virus Sales Share by Type (2015-2020)

Table 42. Global Oncolytic Virus Revenue (Million US$) by Type (2015-2020)

Table 43. Global Oncolytic Virus Revenue Share by Type (2015-2020)

Table 44. Global Oncolytic Virus Price (US$/Unit) by Type (2015-2020)

Table 45. Global Oncolytic Virus Sales (K Units) by Application (2015-2020)

Table 46. Global Oncolytic Virus Sales Market Share by Application (2015-2020)

Table 47. Global Oncolytic Virus Sales Growth Rate by Application (2015-2020)

Table 48. Amgen Oncolytic Virus Corporation Information

Table 49. Amgen Description and Business Overview

Table 50. Amgen Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 51. Amgen Main Product

Table 52. Amgen Recent Development

Table 53. Oncolytics Biotech Oncolytic Virus Corporation Information

Table 54. Oncolytics Biotech Corporation Information

Table 55. Oncolytics Biotech Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 56. Oncolytics Biotech Main Product

Table 57. Oncolytics Biotech Recent Development

Table 58. Viralytics Oncolytic Virus Corporation Information

Table 59. Viralytics Corporation Information

Table 60. Viralytics Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 61. Viralytics Main Product

Table 62. Viralytics Recent Development

Table 63. Transgene SA Oncolytic Virus Corporation Information

Table 64. Transgene SA Corporation Information

Table 65. Transgene SA Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 66. Transgene SA Main Product

Table 67. Transgene SA Recent Development

Table 68. Oncolys BioPharma Oncolytic Virus Corporation Information

Table 69. Oncolys BioPharma Corporation Information

Table 70. Oncolys BioPharma Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 71. Oncolys BioPharma Main Product

Table 72. Oncolys BioPharma Recent Development

Table 73. Targovax Oncolytic Virus Corporation Information

Table 74. Targovax Corporation Information

Table 75. Targovax Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 76. Targovax Main Product

Table 77. Targovax Recent Development

Table 78. PsiOxus Therapeutics Oncolytic Virus Corporation Information

Table 79. PsiOxus Therapeutics Corporation Information

Table 80. PsiOxus Therapeutics Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 81. PsiOxus Therapeutics Main Product

Table 82. PsiOxus Therapeutics Recent Development

Table 83. SillaJen Biotherapeutics Oncolytic Virus Corporation Information

Table 84. SillaJen Biotherapeutics Corporation Information

Table 85. SillaJen Biotherapeutics Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 86. SillaJen Biotherapeutics Main Product

Table 87. SillaJen Biotherapeutics Recent Development

Table 88. Sorrento Therapeutics Oncolytic Virus Corporation Information

Table 89. Sorrento Therapeutics Corporation Information

Table 90. Sorrento Therapeutics Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 91. Sorrento Therapeutics Main Product

Table 92. Sorrento Therapeutics Recent Development

Table 93. Lokon Pharma Oncolytic Virus Corporation Information

Table 94. Lokon Pharma Corporation Information

Table 95. Lokon Pharma Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 96. Lokon Pharma Main Product

Table 97. Lokon Pharma Recent Development

Table 98. Genelux Corporation Oncolytic Virus Corporation Information

Table 99. Genelux Corporation Corporation Information

Table 100. Genelux Corporation Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 101. Genelux Corporation Main Product

Table 102. Genelux Corporation Recent Development

Table 103. Vyriad Oncolytic Virus Corporation Information

Table 104. Vyriad Corporation Information

Table 105. Vyriad Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 106. Vyriad Main Product

Table 107. Vyriad Recent Development

Table 108. TILT Biotherapeutics Oncolytic Virus Corporation Information

Table 109. TILT Biotherapeutics Corporation Information

Table 110. TILT Biotherapeutics Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 111. TILT Biotherapeutics Main Product

Table 112. TILT Biotherapeutics Recent Development

Table 113. Cold Genesys Oncolytic Virus Corporation Information

Table 114. Cold Genesys Corporation Information

Table 115. Cold Genesys Oncolytic Virus Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)

Table 116. Cold Genesys Main Product

Table 117. Cold Genesys Recent Development

Table 118. Sales Base and Market Concentration Rate of Raw Material

Table 119. Key Suppliers of Raw Materials

Table 120. Oncolytic Virus Distributors List

Table 121. Oncolytic Virus Customers List

Table 122. Market Key Trends

Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 124. Key Challenges

Table 125. Global Oncolytic Virus Sales (K Units) Forecast by Type (2021-2026)

Table 126. Global Oncolytic Virus Sales Market Share Forecast by Type (2021-2026)

Table 127. Global Oncolytic Virus Revenue (Million US$) Forecast by Type (2021-2026)

Table 128. Global Oncolytic Virus Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 129. Global Oncolytic Virus Sales (K Units) Forecast by Application (2021-2026)

Table 130. Global Oncolytic Virus Revenue (Million US$) Forecast by Application (2021-2026)

Table 131. Global Oncolytic Virus Sales (K Units) Forecast by Region (2021-2026)

Table 132. Global Oncolytic Virus Sales Market Share Forecast by Region (2021-2026)

Table 133. Global Oncolytic Virus Revenue Forecast by Region (2021-2026) (US$ Million)

Table 134. Global Oncolytic Virus Revenue Market Share Forecast by Region (2021-2026)

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Oncolytic Virus

Figure 2. Global Oncolytic Virus Sales Market Share by Type: 2020 VS 2026

Figure 3. Imlygic Product Picture

Figure 4. Oncorine Product Picture

Figure 5. Others Product Picture

Figure 6. Global Oncolytic Virus Consumption Market Share by Application: 2020 VS 2026

Figure 7. Melanoma

Figure 8. Other Cancers

Figure 9. Global Oncolytic Virus Market Size 2015-2026 (US$ Million)

Figure 10. Global Oncolytic Virus Sales Capacity (K Units) (2015-2026)

Figure 11. Global Oncolytic Virus Market Size Market Share by Region: 2020 Versus 2026

Figure 12. Oncolytic Virus Sales Share by Manufacturers in 2020

Figure 13. Global Oncolytic Virus Revenue Share by Manufacturers in 2019

Figure 14. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Revenue in 2019

Figure 15. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 16. Global Oncolytic Virus Sales Market Share by Region (2015-2020)

Figure 17. Global Oncolytic Virus Sales Market Share by Region in 2019

Figure 18. Global Oncolytic Virus Revenue Market Share by Region (2015-2020)

Figure 19. Global Oncolytic Virus Revenue Market Share by Region in 2019

Figure 20. North America Oncolytic Virus Sales Market Share by Country in 2019

Figure 21. North America Oncolytic Virus Revenue Market Share by Country in 2019

Figure 22. U.S. Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 23. U.S. Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 24. Canada Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 25. Canada Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 26. Europe Oncolytic Virus Sales Market Share by Country in 2019

Figure 27. Europe Oncolytic Virus Revenue Market Share by Country in 2019

Figure 28. Germany Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 29. Germany Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 30. France Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 31. France Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 32. U.K. Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 33. U.K. Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 34. Italy Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 35. Italy Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. Russia Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 37. Russia Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. Asia Pacific Oncolytic Virus Sales Market Share by Region in 2019

Figure 39. Asia Pacific Oncolytic Virus Revenue Market Share by Region in 2019

Figure 40. China Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 41. China Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 42. Japan Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 43. Japan Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. South Korea Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 45. South Korea Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. India Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 47. India Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Australia Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 49. Australia Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Taiwan Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 51. Taiwan Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Indonesia Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 53. Indonesia Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Thailand Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 55. Thailand Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Malaysia Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 57. Malaysia Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Philippines Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 59. Philippines Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Vietnam Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 61. Vietnam Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Latin America Oncolytic Virus Sales Market Share by Country in 2019

Figure 63. Latin America Oncolytic Virus Revenue Market Share by Country in 2019

Figure 64. Mexico Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 65. Mexico Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Brazil Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 67. Brazil Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Argentina Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 69. Argentina Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Middle East and Africa Oncolytic Virus Sales Market Share by Country in 2019

Figure 71. Middle East and Africa Oncolytic Virus Revenue Market Share by Country in 2019

Figure 72. Turkey Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 73. Turkey Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Saudi Arabia Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 75. Saudi Arabia Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. UAE Oncolytic Virus Sales Growth Rate (2015-2020) (K Units)

Figure 77. UAE Oncolytic Virus Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Sales Market Share of Oncolytic Virus by Type (2015-2020)

Figure 79. Sales Market Share of Oncolytic Virus by Type in 2019

Figure 80. Revenue Share of Oncolytic Virus by Type (2015-2020)

Figure 81. Revenue Market Share of Oncolytic Virus by Type in 2019

Figure 82. Global Oncolytic Virus Sales Growth by Type (2015-2020) (K Units)

Figure 83. Global Oncolytic Virus Sales Market Share by Application (2015-2020)

Figure 84. Global Oncolytic Virus Sales Market Share by Application in 2019

Figure 85. Global Revenue Share of Oncolytic Virus by Application (2015-2020)

Figure 86. Global Revenue Share of Oncolytic Virus by Application in 2020

Figure 87. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 88. Oncolytics Biotech Total Revenue (US$ Million): 2019 Compared with 2018

Figure 89. Viralytics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 90. Transgene SA Total Revenue (US$ Million): 2019 Compared with 2018

Figure 91. Oncolys BioPharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 92. Targovax Total Revenue (US$ Million): 2019 Compared with 2018

Figure 93. PsiOxus Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 94. SillaJen Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Lokon Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Genelux Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. Vyriad Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. TILT Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018

Figure 101. Price Trend of Key Raw Materials

Figure 102. Manufacturing Cost Structure of Oncolytic Virus

Figure 103. Manufacturing Process Analysis of Oncolytic Virus

Figure 104. Oncolytic Virus Industrial Chain Analysis

Figure 105. Channels of Distribution

Figure 106. Distributors Profiles

Figure 107. Porter's Five Forces Analysis

Figure 108. North America Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 109. North America Oncolytic Virus Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 110. Europe Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 111. Europe Oncolytic Virus Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 112. Latin America Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 113. Latin America Oncolytic Virus Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 114. Middle East and Africa Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 115. Middle East and Africa Oncolytic Virus Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 116. Asia Pacific Oncolytic Virus Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 117. Asia Pacific Oncolytic Virus Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 118. Bottom-up and Top-down Approaches for This Report

Figure 119. Data Triangulation

Figure 120. Key Executives Interviewed

Amgen

Oncolytics Biotech

Viralytics

Transgene SA

Oncolys BioPharma

Targovax

PsiOxus Therapeutics

SillaJen Biotherapeutics

Sorrento Therapeutics

Lokon Pharma

Genelux Corporation

Vyriad

TILT Biotherapeutics

Cold Genesys

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2291

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase